Literature DB >> 1832633

Suppressor T-cell deficiency in primary sclerosing cholangitis. Case and family study.

A E Kilby1, E L Krawitt, R J Albertini, B F Chastenay, A John.   

Abstract

Primary sclerosing cholangitis is considered to be an autoimmune disease of the liver in which there is an association with the HLA phenotypes B8 and DR3 and in which circulating autoantibodies occur. Abnormalities of immune regulation may be present but whether or not they are primary or acquired is not known. This report is of a patient with primary sclerosing cholangitis who was homozygous for HLA B8 DR3, had a circulating antinuclear antibody, and a defect in nonspecific suppressor T-cell activity despite glucocorticosteroid treatment. Nevertheless, family studies revealed no evidence of an immunoregulatory defect in first-degree relatives despite the presence of Raynaud's phenomenon and malignancy in two sisters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832633     DOI: 10.1007/bf01307511

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  An immunogenetic study of suppressor cell activity in autoimmune chronic active hepatitis.

Authors:  E L Krawitt; A E Kilby; R J Albertini; M S Schanfield; B F Chastenay; P C Harper; R M Mickey; T L McAuliffe
Journal:  Clin Immunol Immunopathol       Date:  1988-02

2.  Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis.

Authors:  G Y Minuk; M Angus; C M Brickman; T J Lawley; M M Frank; J H Hoofnagle; E A Jones
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

3.  Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.

Authors:  K T Nouri-Aria; J E Hegarty; G J Alexander; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1982-11-18       Impact factor: 91.245

4.  Elevated circulating immune complexes in primary sclerosing cholangitis.

Authors:  H C Bodenheimer; N F LaRusso; W R Thayer; C Charland; P J Staples; J Ludwig
Journal:  Hepatology       Date:  1983 Mar-Apr       Impact factor: 17.425

5.  HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease.

Authors:  E Schrumpf; O Fausa; O Førre; J H Dobloug; S Ritland; E Thorsby
Journal:  Scand J Gastroenterol       Date:  1982-03       Impact factor: 2.423

6.  Association of primary sclerosing cholangitis with HLA-B8.

Authors:  R W Chapman; Z Varghese; R Gaul; G Patel; N Kokinon; S Sherlock
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

7.  Immunogenetic studies of autoimmune chronic active hepatitis: HLA, immunoglobulin allotypes and autoantibodies.

Authors:  E L Krawitt; A E Kilby; R J Albertini; M S Schanfield; B F Chastenay; P C Harper; R M Mickey; T L McAuliffe
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

8.  Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

Authors:  R W Chapman; M Cottone; W S Selby; H A Shepherd; S Sherlock; D P Jewell
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

Authors:  G Mieli-Vergani; A Lobo-Yeo; B M McFarlane; I G McFarlane; A P Mowat; D Vergani
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

10.  The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis.

Authors:  L Brinch; P Teisberg; E Schrumpf; I Akesson
Journal:  Scand J Gastroenterol       Date:  1982-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.